Joshua D. Brinen Attorney at Law New York Office jbrinen@brinenlaw.com
Member New York, New Jersey, Florida, California, Texas & Nevada Bar LL.M. in Taxation | |
May 26, 2021
VIA EDGAR ELECTRONIC FILING ONLY
United States Securities and Exchange Commission
Washington, D.C. 20549
Division of Corporation Finance
Attn: Jeffrey Gabor, Esq.
Re: | CannaPharmaRx, Inc. (the “Issuer”) | |
Post-Effective Amendment to Prospectus | ||
Filed: April 15, 2021 | ||
File No.: 333-251016 | ||
Our File No.: CPMD.15 |
Dear Attorney Park:
On behalf of CannaPharmaRx, Inc. (the “Company”), we are hereby filing amendment number 1 the Company’s registration statement on Form S-1 (the “Registration Statement”) filed with the Securities and Exchange Commission on May 14, 2021.
Registration Statement on Form S-1 filed May 14, 2021
General
1. | Because you are ineligible to conduct an at the market offering under Securities Act Rule 415(a)(4), your primary offering of 10 million shares of common stock must be conducted at a fixed price for the duration of the offering. Please revise to disclose the fixed price at which the shares will be sold. |
Response: The primary offering of 10 million shares of common stock have been removed from this registration statement.
Please address any further questions or comments to the undersigned at the above-referenced telephone and e-mail address.
Thank you very much.
Should you have any questions, please do not hesitate to contact me at the New York office or via electronic mail at jbrinen@brinenlaw.com.
Yours truly, | |
Brinen & Associates, LLC | |
/s/ Joshua D. Brinen | |
Joshua D. Brinen |
cc: Client
JDB:jdb